NCT02630355

Brief Summary

This study evaluates the use of remote ischaemic preconditioning for the prevention of dialysis induced cardiac injury. The study uses four arms to test different frequencies of application to ascertain which, if any, is most successful at reducing dialysis induced cardiac injury.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Jan 2016

Typical duration for phase_2

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 15, 2015

Completed
17 days until next milestone

Study Start

First participant enrolled

January 1, 2016

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

October 12, 2020

Status Verified

October 1, 2020

Enrollment Period

2.9 years

First QC Date

December 8, 2015

Last Update Submit

October 8, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • The primary outcome will be a reduction in the number of left ventricular segments undergoing a greater than 30% reduction in longitudinal strain as detected by echocardiography at final study visit

    4 weeks

Secondary Outcomes (4)

  • Number of segments undergoing >30% reduction in longitudinal strain at intervention, week 1, week 2 and week 3 visits

    up to 3 weeks

  • Difference between pre and peak global longitudinal strain at intervention, week 1, week 2 and week 3 visits

    up to 3 weeks

  • Change in pre-dialysis global longitudinal strain between baseline and final study visit

    between 1 and 4 weeks

  • Change in Troponin-T, Plasma IL-6 and N-Type proBNP at intervention, first follow-up and final visit

    up to 4 weeks

Study Arms (4)

Control

SHAM COMPARATOR

Inflation of blood pressure cuff in lower limb to 40mmHg for four cycles of 5 minutes inflation and then deflation

Other: Remote Ischaemic Preconditioning

Low Intensity

ACTIVE COMPARATOR

Inflation of blood pressure cuff in lower limb to 200mmHg for two cycles of 5 minute inflation and then deflation.

Other: Remote Ischaemic Preconditioning

Standard Intensity

ACTIVE COMPARATOR

Inflation of blood pressure cuff in lower limb to 200mmHg for four cycles of 5 minute inflation and then deflation.

Other: Remote Ischaemic Preconditioning

High Intensity

ACTIVE COMPARATOR

Inflation of blood pressure cuff in lower limb to 200mmHg for four cycles of 5 minute inflation and deflation on weekly basis for four consecutive weeks.

Other: Remote Ischaemic Preconditioning

Interventions

Inflation of blood pressure cuff in lower limb

ControlHigh IntensityLow IntensityStandard Intensity

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients having haemodialysis treatment at least 3 times per week at a London Health Sciences Centre facility
  • Male and female, age≥16 years old.

You may not qualify if:

  • Exposure to haemodialysis for \<90 days prior to recruitment
  • Severe heart failure (New York Heart Association grade IV)
  • Cardiac transplant recipients
  • Mental incapacity to consent
  • Declined to participate
  • Taking cyclosporin
  • Taking ATP-sensitive potassium channel opening or blocking drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cardiovascular Diseases

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

December 8, 2015

First Posted

December 15, 2015

Study Start

January 1, 2016

Primary Completion

December 1, 2018

Study Completion

December 1, 2018

Last Updated

October 12, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share